NEW YORK (GenomeWeb) – Natera today provided preliminary financial guidance for fiscal years 2015 and 2016.

The San Carlos, California-based molecular diagnostic company said it expects 2015 revenues to be in the range of $175 million to $190 million, 10 percent to 20 percent higher than its 2014 revenues of $159.3 million. It said it expects 2016 revenues to be in the range of $220 million to $240 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.